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Summary
Objective: To compare temporomandibular joint (TMJ) condylar cartilage cells in vitro to hyaline cartilage cells cultured in a three-dimensional
(3D) environment for tissue engineering of mandibular condylar cartilage.
Design: Mandibular condylar cartilage and hyaline cartilage cells were harvested from pigs and cultured for 6 weeks in polyglycolic acid (PGA)
scaffolds. Both types of cells were treated with glucosamine sulfate (0.4 mM), insulin-like growth factor-I (IGF-I) (100 ng/ml) and their combi-
nation. At weeks 0 and 6, cell number, glycosaminoglycan (GAG) and collagen content were determined, types I and II collagen were visu-
alized by immunohistochemistry and GAGs were visualized by histology.
Results: Hyaline cartilage cells produced from half an order to a full order of magnitude more GAGs and collagen than mandibular condylar
cartilage cells in 3D culture. IGF-I was a highly effective signal for biosynthesis with hyaline cartilage cells, while glucosamine sulfate de-
creased cell proliferation and biosynthesis with both types of cells. In vitro culture of TMJ condylar cartilage cells produced a ﬁbrous tissue
with predominantly type I collagen, while hyaline cartilage cells formed a ﬁbrocartilage-like tissue with types I and II collagen. The combination
of IGF and glucosamine had a synergistic effect on maintaining the phenotype of TMJ condylar cells to generate both types I and II collagen.
Conclusion: Given the superior biosynthetic activity by hyaline cartilage cells and the practical surgical limitations of harvesting cells from the
TMJ of a patient requiring TMJ reconstruction, cartilage cells from elsewhere in the body may be a potentially better alternative to cells har-
vested from the TMJ for TMJ tissue engineering. This ﬁnding may also apply to other ﬁbrocartilages such as the intervertebral disc and knee
meniscus in applications where a mature cartilage cell source is desired.
ª 2008 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Temporomandibular joint (TMJ) disorders resulting from ar-
thritis, ankylosis, traumas, internal derangement and/or
other afﬂictions can ravage TMJ structures that have limited
capacity for regeneration. Tissue engineering may provide
an ideal solution, especially when severe degeneration oc-
curs1,2. Although our long-term goal is to regenerate the
whole mandibular condyle of the TMJ, the speciﬁc focus
of the current study was the condylar cartilage, where cell
sources and signals were investigated. The purpose of
this study was to compare the behavior of mandibular con-
dylar cartilage cells and ankle (hyaline) cartilage cells under
the regulation of insulin-like growth factor-I (IGF-I) and glu-
cosamine sulfate.
The composition and structure of mandibular condylar
cartilage (henceforth referred to as TMJ condylar cartilage)
differ from hyaline cartilage. Hyaline cartilage cells are
chondrocytes, and hyaline cartilage can be divided into
four zones: superﬁcial, middle, deep and calciﬁed. In con-
trast, TMJ condylar cartilage has both ﬁbrocartilaginous
and hyaline-like character, with a thin proliferative zone
that separates the ﬁbrocartilaginous ﬁbrous zone at the*Address correspondence and reprint requests to: Dr Michael S.
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346surface from the hyaline-like mature and hypertrophic
zones below. Unlike hyaline cartilage, TMJ condylar carti-
lage contains predominantly ﬁbroblasts and collagen I in
the superﬁcial ﬁbrous zone3e5. Undifferentiated mesenchy-
mal cells are distributed in the proliferative zone, serving as
a cell reservoir to provide cells for the ﬁbrous zone and un-
derlying zones6e10. The underlying mature and hypertro-
phic zones include differentiated chondrocytes and the
collagen is both types I and II3e5,11. From the standpoint
of embryonic origin, TMJ condylar cartilage is categorized
as a secondary cartilage formed by periosteum or endos-
teum, while hyaline cartilage is a primary cartilage, which
precedes bone formation. TMJ condylar cartilage falls un-
der the classiﬁcation of ﬁbrocartilage, with a strong pres-
ence of both collagen types I and II5,11. However, hyaline
cartilage contains predominately collagen type II in all
zones12. These contrasting structures make it imperative
to investigate and compare the responses of TMJ condylar
cartilage cells and hyaline cartilage cells to biological sig-
nals and biodegradable scaffolds.
Previous tissue engineering studies of TMJ condylar carti-
lages utilized cells from the condyle itself13, hyaline cartilage
cells14, ﬁbroblasts15,16 and stemcells13,17e24 as cell sources.
An early attempt conducted by Weng et al.14 seeded bovine
hyaline chondrocytes from the forelimbs onto the surface of
a polyglycolic acid/polylactic acid (PGA/PLA) scaffold as
a cartilage layer. Hollister and colleagues15,16 also seeded
bone morphogenetic protein (BMP)-transduced ﬁbroblasts
into scaffolds. In both studies, cartilage formation was
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more, bone marrow and umbilical cord mesenchymal
stromal cells13,17e24 were introduced to TMJ tissue engineer-
ing, demonstrating the feasibility of creating a tissue-
engineered mandibular condyle in the form of two stratiﬁed
layers. In these studies, the positive immunohistochemical
(IHC) staining for types I and II revealed the existence of
a ﬁbrocartilage. Although most previous studies used stem
cells for TMJ tissue engineering13,17e24, an advantage that
mature cells possess over various types of stem cells is the
absence of the variable of differentiation and reduced possi-
bility of metaplasia. This study thus aimed to compare TMJ
condylar cartilage cells to hyaline cartilage cells for tissue
engineering applications.
Although the cell behavior of TMJ condylar cartilage and
hyaline cartilage has been extensively investigated, there
are only three studies comparing the respective cell types,
performed in newborn rat explant culture by a single
group5,25,26. These studies revealed that basic ﬁbroblast
growth factor (bFGF), IGF-I and transforming growth factor
beta (TGF-b) stimulated higher cell proliferation in the TMJ
condylar explants than in the femoral head explants. IGF-I
increased glycosaminoglycan (GAG) formation, while
bFGF and TGF-b decreased GAG production in both
types of cartilage. It must be noted that these studies
used newborn rat condyles, which grew faster than mature
condyles27, whereas in the current study, cells were
isolated from mature porcine mandibular condylar and
ankle cartilage. In a two-dimensional (2D) environment
using mature cells28, IGF-I promoted cell proliferation
and biosynthesis for both types of cells. Therefore, based
on both explant and monolayer cell culture, IGF-I was
chosen in our three-dimensional (3D) study to regulate
cell growth and biosynthesis.
Glucosamine has been scarcely tested in tissue engi-
neering applications, with a handful of recent studies. One
recent investigation revealed that glucosamine hydrochlo-
ride up-regulated matrix production at concentrations
between 0 and 2 mM29. Glucosamine sulfate has been
shown in vitro to promote aggrecan production30,31, and to
inhibit matrix degrading protein production in chondro-
cytes30. In our 2D monolayer culture28, glucosamine sulfate
also demonstrated an ability to signiﬁcantly promote GAG
and collagen production and to outperform growth factors
in certain instances (between 0 and 0.4 mM) for both TMJ
condylar cartilage cells and ankle cartilage. Consequently,
besides IGF-I at 100 ng/ml, glucosamine at 0.4 mM was
adopted and the synergistic effects of IGF-I and glucos-
amine were also investigated in the current study.
Non-woven PGA scaffolds have been broadly exploited
in both hyaline32e34 and ﬁbrocartilage cartilage35e37 tissue
engineering, due to its good biocompatibility and biodegrad-
ability. Our previous study13 also demonstrated that
non-woven PGA meshes did support proliferation and bio-
synthesis of TMJ condylar cartilage cells as evidenced by
a signiﬁcant increase in cell number and the presence of
types I and II collagen and GAGs throughout the constructs.
Therefore, in this study, non-woven PGA scaffolds were
seeded with porcine cartilage cells from mature TMJ condy-
lar cartilage and hyaline cartilage from ankles. Exogenous
signals including glucosamine sulfate (0.4 mM) and IGF-I
(100 ng/ml) and their combination were employed to regu-
late cell proliferation and extracellular matrix production.
The comparison between these two types of cells provides
critical steps in demonstrating that hyaline cartilage cells
may be a promising mature cell source for TMJ condylar
cartilage tissue engineering.Materials and methodsCELL HARVESTINGHog heads and ankles (Chester white breed, female, age 8 months)
were acquired from Winchester Meat Processing (Winchester, KS, USA).
The TMJ was ﬁrst removed en bloc with capsule intact and placed into
100% ethanol for 20 min. The TMJ was scrubbed using a sterile iodine
pad, then the joint capsule was broken and the disc was removed in a ster-
ile manner with a scalpel in a tissue culture hood. TMJ condylar cartilage
was removed by chopping cartilage from the surface of the TMJ condyle,
washed with sterile phosphate buffered saline (PBS), minced, and di-
gested for 24 h in 2 mg/ml type II collagenase (394 U/mg; Worthington Bio-
chemical; Lakewood, NJ, USA). The cell solution was centrifuged and cells
were resuspended in a cell culture medium, consisting of Dulbecco’s Mod-
iﬁed Eagle medium (Invitrogen; Carlsbad, CA, USA), 10% fetal bovine se-
rum (FBS; Gemini; West Sacramento, CA, USA), 25 mg/ml ascorbic acid
(Sigma; St. Louis, MO, USA), 1% non-essential amino acids (Invitrogen;
Carlsbad, CA, USA) and 1% penicillinestreptomycinefungizone (Invitro-
gen; Carlsbad, CA, USA). Cells were fed every other day until conﬂuent.
The conﬂuent cell population was trypsinized and labeled as passage 1.
The procedure to obtain cartilage cells from ankles was similar to harvest-
ing TMJ condylar cartilage cells, although more straightforward. Brieﬂy,
skin was removed, the joint was sterilized using an iodine pad, the joint
capsule was broken, and cartilage was obtained and minced. After diges-
tion, the cells were resuspended, cultured in the ﬂasks, and labeled as
passage 1.CELL SEEDING AND GROWTH FACTOR INCORPORATIONA non-woven PGA mesh (50 mg/cc; Synthecon; Houston, TX, USA) was
punched into disc-shape scaffolds with a 5 mm diameter and 2 mm thick-
ness, and then sterilized with ethylene oxide. After sterilization, the scaffolds
were aired in sterilization pouches under a fume hood for 1 day, then wetted
with sterile ﬁltered ethanol for 5 min and two washes of sterile PBS. The scaf-
folds were then soaked in the cell culture medium for 1 day and then re-
moved for cell seeding. P1 cells were seeded on the PGA scaffolds at 50
million cells/ml of scaffold. Highly concentrated cell solution (500 ml) was dis-
pensed slowly onto scaffolds in 24-well plates, which were set on an orbital
shaker at 150 rpm for 12 h. After 12 h, 500 ml of fresh medium was added.
After 24 h, an additional 1 ml of medium was added and cells were allowed
to attach statically in the medium for another day. After allowing 2 days for
seeding and attachment (recorded as day 1), the medium was replaced by
2 ml of either fresh medium or the medium supplemented with either growth
factor or glucosamine. There were a total of eight groups in this study, includ-
ing the TMJ condylar and hyaline cartilage cells treated by IGF (100 ng/ml;
Pepro Tech; Rocky Hill, NJ, USA), D-glucosamine 6-sulfate (0.4 mM, corre-
sponding to 100 mg/ml; Sigma; St. Louis, MO, USA) and their combination
(100 ng/ml IGF and 0.4 mM glucosamine) and their respective controls (cul-
tured in fresh medium without IGF and glucosamine treatment). Scaffolds
were cultured in 2 ml of medium for 6 weeks and half of the medium was
changed every other day.BIOCHEMICAL ANALYSIS AND IHC STAININGScaffolds were examined at weeks 0 and 6 for cell number, GAG and hy-
droxyproline content. Cell number was measured using a Picogreen assay
(Molecular Probes; Eugene, OR, USA) with a conversion factor of 7.7 pg
DNA/cell38. The GAG content was quantiﬁed by a dimethylmethylene blue
(DMMB) dye assay (Biocolor; Newtownabbey, Northern Ireland)38. The hy-
droxyproline content was examined by a hydroxyproline assay (Accurate;
Westbury, NY, USA)38. A conversion factor of 11.5 was determined in a pre-
liminary study for converting hydroxyproline mass to collagen mass. Histo-
logical analysis was performed using a Safranin-O/fast green stain. IHC
staining of types I and II collagen was performed in a Biogenex i6000 autos-
tainer (San Ramon, CA, USA)13. The mouse monoclonal IgG anti-collagen I
(1:1500 dilution) (Accurate Chemical; Westbury, NY, USA), mouse monoclo-
nal IgG anti-collagen II (1:1000 dilution) (Chondrex; Redmond, WA, USA)
and mouse monoclonal IgG anti-aggrecan (1:50 dilution) (Abcam; Cam-
bridge, MA, USA) antibodies were chosen as primary antibodies. The strep-
tavidin-linked horse anti-mouse IgG secondary antibody, ABC detection kit,
and DAB (brown) and VIP (purple) substrate kits were obtained from Vector
Laboratories (Burlingame, CA, USA). Double IHC staining of types I and II
collagen was performed for sagittal sections of native ankle and TMJ tissues.
Type I collagen staining was ﬁrst conducted by following the above proce-
dure with VIP as the substrate, avidin and biotin (Vector Laboratories)
were then added in a blocking step to prevent the interaction between the
ﬁrst and second sets of labeling reagents, and type II collagen staining
was ﬁnally performed with DAB as the substrate. Negative controls were pre-
pared by omitting the primary antibodies, and the absence of non-speciﬁc
staining was conﬁrmed.
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lyzed by an analysis of variance (ANOVA) followed by a Fisher’s Protected
Least Signiﬁcance Difference post hoc test. Three-way ANOVAs with inter-
action were used to determine whether there were differences among
time-points, different treatments, or cell types. A statistical threshold of
P< 0.05 was used to indicate whether there were statistically signiﬁcant dif-
ferences among groups.ResultsCELL NUMBERFig. 2. GAG content per construct at weeks 0 and 6 (n¼ 4). Gluco
denotes glucosamine. Symbol * means statistically signiﬁcant dif-
ference between ankle groups and TMJ groups. Symbol # means
statistically signiﬁcant difference compared to the respective control
group. Error bars represent standard deviations.Over 6 weeks of culture, the ankle groups had signiﬁ-
cantly more cells than the TMJ groups (P< 1012)
(Fig. 1). At week 0, there were 1.44 times more cells at-
tached to scaffolds in ankle groups than in TMJ groups
(P< 0.05), although two types of cells were seeded onto
scaffolds at the same density (1.96 million cells per con-
struct). At week 6, the average cell number of ankle groups
was 1.63 million cells per construct, while the cell count of
TMJ groups was 0.82 million cells per construct
(P< 1012). With regard to IGF and glucosamine, ankle
cells were more sensitive than TMJ cells. In all ankle
groups, except for the glucosamine group, cell numbers in-
creased from week 0 to week 6 (P< 104), while cell num-
bers in TMJ groups did not exhibit any statistically
signiﬁcant differences from week 0 to week 6. In compari-
son to their respective controls, signiﬁcant differences in
cell numbers were not observed for either cell type. How-
ever, IGF and the combination of IGF and glucosamine in
ankle groups promoted cell number compared to the glu-
cosamine group (P< 0.001). In fact, the glucosamine
groups had 15% and 13% decreases in cell number com-
pared to the control for both the ankle and TMJ groups
(not statistically signiﬁcant), respectively.GAG CONTENTThere was no signiﬁcant difference in GAG content at
week 0 between ankle and TMJ cells (Fig. 2). The average
GAG production per construct of 107.4 mg in ankle groups
was an order of magnitude higher than the average content
of 11.3 mg per construct in TMJ groups after 6 weeks of cul-
ture (P< 1011). Ankle groups at week 6, with the exception
of the glucosamine group, had drastically increased GAG
production over time, as the IGF, combination and theFig. 1. Cell number per construct at weeks 0 and 6 (n¼ 4). Gluco
denotes glucosamine. Symbol * means statistically signiﬁcant dif-
ference between ankle groups and TMJ groups. Error bars repre-
sent standard deviations.control groups had 8.3 (P< 109), 7.0 (P< 108), and 4.1
(P< 104) times higher GAG contents than at week 0, re-
spectively, while there was no signiﬁcant difference among
TMJ groups. Both IGF and the combination promoted GAG
production, with 1.79 and 1.49 times more GAGs in ankle
groups than in the control (P< 104 and 0.05, respectively),
whereas glucosamine lessened the GAG production by
49% (P< 0.01).HYDROXYPROLINE CONTENTAs with cell number and GAG content, hydroxyproline
content in ankle groups was signiﬁcantly higher than in
TMJ groups (P< 1011) (Fig. 3). Despite the fact that the
ankle group had 5.8 times more hydroxyproline than the
TMJ group at week 0, there was no statistically signiﬁcant
difference between them. In comparison to week 0, hydrox-
yproline content in ankle groups at week 6 increased over
time by 8.9, 5.2, 8.0, and 6.0 times with the IGF groupFig. 3. Hydroxyproline content per construct at weeks 0 and 6
(n¼ 4) (multiply by a factor of 11.5 for collagen content). Gluco de-
notes glucosamine. Symbol * means statistically signiﬁcant differ-
ence between ankle groups and TMJ groups. Symbol # means
statistically signiﬁcant difference compared to the respective control
group. Error bars represent standard deviations.
349Osteoarthritis and Cartilage Vol. 17, No. 3(P< 109), the glucosamine group (P< 104), their combi-
nation (P< 108) and the control (P< 105), respectively,
while no signiﬁcant differences were detected among TMJ
groups. IGF and the combination in ankle groups had
26.0 and 24.0 mg of hydroxyproline per construct, which
were 48% (P< 0.005) and 35% (P< 0.05) increases com-
pared to the control, respectively.IHC ANALYSESAt week 6, IHC analysis revealed a moderate staining of
type I collagen and an intense staining of type II collagen in
ankle groups (Fig. 4), with especially intense regions of col-
lagen II staining in the IGFeglucosamine combination
group. In the native ankle cartilage, type II collagen was
dominant (Fig. 5). The constructs in TMJ groups demon-
strated a signiﬁcant presence of type I collagen and a min-
ute amount of type II collagen (Fig. 4). It must be noted that
the group combining IGF and glucosamine in the TMJ
group demonstrated much more intense staining of type II
collagen than all other TMJ groups. In native TMJ condylar
cartilage, type I collagen was dominant in the superﬁcial
zone, abundant type I and moderate II collagen were ob-
served in the proliferative zone, and type II collagen was
dominant in the mature and hypertrophic zones (Fig. 5). In
general, ankle cells had a weaker staining of type I collagen
than TMJ cells and a stronger staining of type II collagen.Fig. 4. IHC test for types I and II collagen at week 6 (n¼ 2). Positive stain
and CII¼ type IIIHC also revealed a more abundant presence of aggrecan
in the IGF and the combination groups with ankle cells,
compared to other ankle groups and all TMJ groups
(Fig. 6), which was further conﬁrmed by the GAG content
from DMMB assays.
Discussion
In this study, mature porcine cartilages were used since
the pig has been identiﬁed as a suitable model for TMJ
tissue engineering strategies2,39e42, although different
species and ages43 might lead to different results. The
two types of cartilage cells were shown to differ in vitro in
cell proliferation, GAG and collagen production, and colla-
gen type. In addition, the results revealed that the composi-
tions of tissue-engineered cartilages were different from
their respective native tissues. Loading conditions may con-
tribute to the different behaviors of the respective cell types,
although it should be made clear that the TMJ is a load-
bearing joint42,44. To the best of our knowledge, this was
the ﬁrst effort to compare cartilage cell sources for TMJ tis-
sue engineering, as a ﬁrst step in demonstrating that it may
not be necessary to use cells from the same tissue when
selecting a mature cell source for ﬁbrocartilage regenera-
tion. Moreover, this is the ﬁrst example of collagens I and
II double immunostaining of condylar cartilage, to the best
of our knowledge.ing is purple in color. The scale bar is 100 mm. CI¼ type I collagen
collagen.
Fig. 5. Double IHC staining for types I and II collagen in sagittal sec-
tions from native tissues. Positive staining of type I collagen is
brown in color. Positive staining of type II collagen is purple in color.
Note that the hyaline cartilage is stained almost exclusively for type
II collagen, whereas in sharp contrast the mandibular condylar car-
tilage consists of distinct zones dominated either by collagen I (su-
perﬁcial zone) or collagen II (mature and hypertrophic zones)
staining. The scale bar is 100 mm.
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were less proliferative in a 3D environment. The signiﬁcant
difference at week 0 in cell number between TMJ condylar
cells and hyaline cartilage cells revealed that TMJ condylar
cells had an inferior ability to attach onto PGA scaffolds
compared to hyaline cartilage cells. This inferior attachment
ability would likely explain the lower cellularity of TMJ
groups at 6 weeks, given the superior proliferation rate of
TMJ condylar cartilage cells in monolayer culture45. The
exploration of new biomaterials may enhance the adhering
ability of TMJ cells, such as Arg-Gly-Asp (RGD) modiﬁed
poly(lactic-co-glycolic acid) (PLGA)46 and poly-L-lactic
acid (PLLA)47. During the 6 weeks of culture, TMJ condylar
cells maintained a relatively constant cell number, indicating
that TMJ condylar cartilage cells exhibited a behavior more
similar to ﬁbrocartilage cells such as TMJ disc cells and
knee meniscus cells, although they were more proliferative
in monolayer culture than ankle hyaline cartilage45. In fact,
Almarza and Athanasiou35 reported that in vitro culture of
ﬁbrocartilage cells (TMJ disc cells) even demonstrated a de-
crease in cell number over a 4-week period. Mesenchymal
stem cells (human umbilical cord mesenchymal stromal
cells) in a chondrogenic medium also had a decreased or
stable cell number in PGA scaffolds over 4 weeks of culture
in a ﬁbrocartilage tissue engineering application48. The rel-
atively invariable cellularity with TMJ condylar cells implied
that a higher seeding density might be necessary.TMJ condylar cells were inferior in extracellular matrix syn-
thesis to hyaline cartilage cells. The ratios of GAG to collagen
content in the TMJ groups were 0.25 on average, which is
higher than the ratios in native tissues, while this ratio in
the ankle groups was 0.47, which is comparable to native tis-
sues49e51. The dominance of type I relative to type II collagen
in TMJ groups (except for the combination of IGF and glucos-
amine) might be unexpected since there is abundant type II
collagen present in the mature and hypertrophic zones of na-
tive TMJ condylar cartilage, though type I collagen produced
by ﬁbroblasts in the ﬁbrous zone likely contributed to colla-
gen production. A strong IHC staining of type II collagen
and a moderate staining of type I collagen were observed
in hyaline cartilage groups, indicating the formation of a ﬁbro-
cartilage-like tissue, which is the goal with TMJ condylar car-
tilage regeneration. The abundant type I collagen in TMJ
groups and moderate type I collagen presence in ankle
groups together suggest the inevitable shift of TMJ and ankle
cell phenotypes during in vitro culture, due to the differences
between the in vitro and in vivo microenvironments, such as
mechanical conditions, bioactive signals, and the exchange
of nutrients and wastes. The dedifferentiated hyaline chon-
drocytes may be redifferentiated in an agarose gel52, algi-
nate beads53, by use of high density culture54, by
substituting serum with the combination of TGF-b2 and
IGF-I55, or by coating a surface with chondrogenic molecules
such as aggrecan56,57. However, it is still questionable
whether redifferentiated chondrocytes have the ability to
generate a properly assembled matrix58.
TMJ condylar cells were less responsive to the stimula-
tion of exogenous signals than hyaline cartilage cells, in
that the IGF and IGF/glucosamine combination both signif-
icantly up-regulated collagen and GAG biosynthesis with
hyaline cartilage cells, whereas no signals produced statis-
tically signiﬁcant differences for the TMJ cells compared to
the control. It was unanticipated that glucosamine at 0.4 mM
exhibited a noticeable inhibition of biosynthesis with ankle
cartilage cells, although this concentration was the best
for the up-regulation of GAG and collagen in our preliminary
monolayer studies28, indicating that further optimization of
glucosamine concentrations in a 3D environment is re-
quired. However, Mroz and Silbert59,60 also revealed that
glucosamine chloride did not stimulate the formation of
chondroitin sulfate with rat chondrocytes and even inhibited
it at speciﬁc concentrations. Glucosamine is an important
building block of proteoglycans in cartilage. However, a pre-
vious study59 revealed that exogenous glucosamine did not
participate in the pathway to produce GAGs, but rather
played a role as a signal to regulate GAG and collagen pro-
duction. Indeed, in the current study, the combination of IGF
and glucosamine demonstrated a critical ability to retain
type II collagen synthesis with TMJ condylar cells during
in vitro culture, although the inherent mechanism needs to
be further investigated in the future.
Ideally, tissue-engineered TMJ condylar cartilage should
mimic the native zonal structure to achieve a functional con-
dylar replacement. One strategy to accomplish this could be
to separately harvest cells from the different zones of the
condylar cartilage. However, the separation of different cell
populations from their respective layers is limited by the ac-
curate dissection of different layers of TMJ condylar cartilage
due to the irregular zonal distribution. Countercurrent centri-
fugation, a technique extensively used with hematopoietic
progenitor cells, was utilized in a previous study to elutriate
ﬁve different fractions of cells from TMJ condylar cells based
on the different sizes of cells61. Characterization of these
cells suggested that ﬁbroblast-like cells, mesenchymal
Fig. 6. IHC staining for aggrecan at week 6 (n¼ 2). Arrows indicate examples of positive staining of aggrecan (light purple color). The black
color indicates PGA debris. The scale bar is 400 mm.
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these ﬁve populations according to cell volume, alkaline
phosphatase content, proteoglycan production, and collagen
types. Seeding these cells into a stratiﬁed scaffold would be
interesting but challenging work in the future.
In vitro culture of both types of cartilage cells appeared to
exhibit a phenotypic shift during the 6 weeks of culture in
PGA scaffolds. In vitro tissue engineering of TMJ condylar
cartilage using mature cells produced a ﬁbrous tissue with
dominant type I collagen. The combination of IGF and glucos-
amine demonstrated the ability to maintain the expression of
both types I and II collagen with TMJ condylar cartilage cells.
In vitro culture of hyaline cartilage cells resulted in the ﬁbro-
cartilage-like tissue genesis with both types I and II collagen.
Most importantly, cell number and extracellular matrix con-
tent in the hyaline cartilage cell groups were signiﬁcantly
higher than in the TMJ condylar cartilage cell groups. Further-
more, from a clinical perspective, it is more reasonable to ob-
tain cells from hyaline cartilage (or perhaps costal cartilage)than from degenerated TMJ condylar cartilage, in which the
healthy cells are very limited, or from a healthy contralateral
TMJ, which may lead to bilateral dysfunction. Therefore,
given the importance of the superior biosynthetic activity by
hyaline cartilage cells, and the clinical difﬁculty in obtaining
donor cartilage, hyaline cartilage cells may be a more prom-
ising mature cell source than the TMJ itself for TMJ condylar
cartilage tissue engineering, a principle which may also apply
to other ﬁbrocartilages such as the intervertebral disc and
knee meniscus. In the future, experiments will include opti-
mizing glucosamine concentrations in 3D culture, designing
zonal scaffolds for seeding different populations of cells,
and evaluating mechanical properties of tissue-engineered
constructs for long-term culture (>6 weeks).Conﬂict of interest
There are no conﬂicts of interest for any author.
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